BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4034460)

  • 1. The clinical value of Haemoccult and Fecatwin in the detection of colorectal neoplasia in hospital and general practice patients.
    Barrison IG; Parkins RA
    Postgrad Med J; 1985 Aug; 61(718):701-4. PubMed ID: 4034460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.
    Armitage N; Hardcastle JD; Amar SS; Balfour TW; Haynes J; James PD
    Br J Cancer; 1985 Jun; 51(6):799-804. PubMed ID: 4005139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of faecal occult blood testing in the detection of colorectal cancer.
    Hardcastle JD; Farrands PA; Balfour TW; Chamberlain J; Amar SS; Sheldon MG
    Lancet; 1983 Jul; 2(8340):1-4. PubMed ID: 6134884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five guaiac-based tests for occult blood in faeces compared in vitro and in vivo.
    Adlercreutz H; Partanen P; Virkola P; Liewendahl K; Turunen MJ
    Scand J Clin Lab Invest; 1984 Oct; 44(6):519-28. PubMed ID: 6333067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of colorectal cancer using faecal occult blood tests.
    Elliot MS; Levenstein JH; Wright JP; Kottler RE
    S Afr Med J; 1984 Aug; 66(6):219-21. PubMed ID: 6463799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological detection of faecal occult blood in colorectal cancer.
    Turunen MJ; Liewendahl K; Partanen P; Adlercreutz H
    Br J Cancer; 1984 Feb; 49(2):141-8. PubMed ID: 6696817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal occult blood testing in the detection of colorectal cancer.
    Elliot MS; Levenstein JH; Wright JP
    Br J Surg; 1984 Oct; 71(10):785-6. PubMed ID: 6487979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal carcinoma: an analysis of the sensitivity of haemoccult.
    Thomas WM; Pye G; Hardcastle JD; Walker AR
    Br J Surg; 1992 Aug; 79(8):833-5. PubMed ID: 1393487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of investigations for colorectal carcinoma in symptomatic patients.
    Kalra L; Hamlyn AN
    Postgrad Med J; 1988 Sep; 64(755):666-8. PubMed ID: 3251216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening tests for colon cancer - a new comparison Haemoccult - hemoFEC and review of 9 years clinical experience with Haemoccult (author's transl)].
    Gnauck R
    Z Gastroenterol; 1982 Feb; 20(2):84-92. PubMed ID: 6977955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemoccult does not reduce the need for colonoscopy in surveillance after curative resection for colorectal cancer.
    Hall C; Griffin J; Dykes PW; Williams JA; Keighley MR
    Gut; 1993 Feb; 34(2):227-9. PubMed ID: 8432478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for symptomless colorectal cancer by testing for occult blood in general practice.
    Hardcastle JD; Balfour TW; Amar SS
    Lancet; 1980 Apr; 1(8172):791-3. PubMed ID: 6102678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal occult blood testing in symptomatic patients: comparison of three tests.
    Tate JJ; Northway J; Royle GT; Taylor I
    Br J Surg; 1990 May; 77(5):523-6. PubMed ID: 2354334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for colorectal cancer with a test for occult blood in stool (author's transl)].
    Uhlig K; Jacobasch KH; Lampe J; Wiedemann FH; Schönberner H
    Arch Geschwulstforsch; 1981; 51(8):717-20. PubMed ID: 7340717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity of the haemoccult test in colorectal tumours (author's transl)].
    Schewe S; Feifel G; Heldwein W; Weinzierl M; Wolf W; Bolte HD; Konrad E
    Dtsch Med Wochenschr; 1979 Feb; 104(7):253-6. PubMed ID: 761519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Developments in the diagnosis of colorectal carcinoma. Comparison of various diagnostic groups].
    Matek W; Frühmorgen P; Altendorf A; Hermanek P
    Fortschr Med; 1979 Jan; 97(2):65-8. PubMed ID: 310411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of occult blood tests over a six-day period.
    Farrands PA; Hardcastle JD
    Clin Oncol; 1983 Sep; 9(3):217-25. PubMed ID: 6616996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experience with occult blood test in 8784 patients (author's transl)].
    Weiss W; Samec HJ; Gulz W; Ortner H; Rüdiger E; Neumayr A
    Wien Klin Wochenschr; 1981 May; 93(9):291-6. PubMed ID: 6973245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of large-bowel cancers detected by occult blood test in asymptomatic patients.
    Nivatvongs S; Gilbertsen VA; Goldberg SM; Williams SE
    Dis Colon Rectum; 1982; 25(5):420-1. PubMed ID: 7094779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia.
    Winawer SJ; Andrews M; Flehinger B; Sherlock P; Schottenfeld D; Miller DG
    Cancer; 1980 Jun; 45(12):2959-64. PubMed ID: 6992968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.